期刊文献+

甘氨酸席夫碱Ni(Ⅱ)配合物法不对称合成3-甲基谷氨酸 被引量:1

Asymmetric synthesis of 3-methyl glutamic acid via the BPB-Ni(Ⅱ)-Gly comple
下载PDF
导出
摘要 采用甘氨酸席夫碱Ni(Ⅱ)配合物法合成(2S,3S)-3-甲基谷氨酸及(2R,3R)-3-甲基谷氨酸。S-2-N-(N′-苄基-S-脯氨酰)-氨基二苯甲酮-镍(Ⅱ)-甘氨酸(BPB-Ni(Ⅱ)-Gly)复合物在碱性条件下,与巴豆酸甲酯发生Michael加成反应,得到两种构型(2S,3S)、(2R,3R)甘氨酸席夫碱Ni(Ⅱ)巴豆酸甲酯复合物中间体,产率分别为77%与21%。经水解生成相应的(2S,3S)-3-甲基谷氨酸、(2R,3R)-3-甲基谷氨酸与手性辅基2-N-(N′-苄基-S-脯氨酰)-氨基二苯甲酮(BPB)。其中,手性辅基的回收率达90%。 (2S,3S)-3-Methyl glutamic acid and(2R,3R)-3-methyl glutamic acid were synthesized via Ni(Ⅱ) complex of glycine acid′s Schiff base,which reacted upon trans-methyl crotonate under an alkaline condition.After the Micheal addition reaction,two chiral complexes of Schiff base of(2S,3S) and(2R,3R) were obtained,with their yield reaching 77% and 21%,respectively.Finally,(2S,3S)-3-methyl glutamic acid was obtained via hydrolysis of(2S,3S)-Schiff base and separation of the hydrolyzed mixture by means of an ion-exchange column.And(2R,3R)-3-methyl glutamic acid was obtained by hydrolysis of(2R,3R)-Schiff base in the same way.The chiral auxiliary can be recovered at a yield of exceeding 90%.
出处 《化学试剂》 CAS CSCD 北大核心 2011年第2期107-110,120,共5页 Chemical Reagents
基金 国家重点基础研究发展计划("973"计划)项目(2009CB724700) 国家自然科学基金资助项目(30900009)
关键词 (2s 3S)-3-甲基谷氨酸 (2R 3R)-3-甲基谷氨酸 BPB-Ni(Ⅱ)-Gly复合物 MICHAEL加成 (2S,3S)-3-methyl-glutamic acid (2R,3R)-3-methyl-glutamic acid BPB-Ni(Ⅱ)-Gly complex Michael addition
  • 相关文献

参考文献12

  • 1TEDESCO K L, RYBAK M J. Daptomycin [ J ]. Pharmacotherapy,2004,24( 1 ) :41-57.
  • 2林琳.治疗革兰阳性菌感染的新型药物[J].中国药业,2009,18(13):84-86. 被引量:5
  • 3史丽娟,石磊.新型抗革兰阳性菌药物——达托霉素[J].中国医药导刊,2008,10(7):1100-1102. 被引量:12
  • 4王玮,穆青.从天然产物到药物——达托霉素的发展历程[J].国外医药(抗生素分册),2009,30(2):59-62. 被引量:11
  • 5WEHBE J, ROLLAND V, ROUMESTANT M L, et al. Glutamate transporter blockers enantiomerically pure(2S, 3 S ) -and ( 2R, 3R) -3-methyl glutamic acids [ J ]. Tetrahed. ron :Asymmetry,2003,14(9) : 1 123-1 126.
  • 6HERDEIS C, KELM B. A stereoseletive synthesis of 3- substituted (S)-pyroglutamic and glutamic acids via OBO ester derivatives [ J ]. Tetrahedron, 2003,59 ( 2 ) : 217-229.
  • 7OBA M ,SAEQUSA T,NISHIYA N. Synthesis of non-proteinogenic amino acids using Michael addition to unsaturated orthopyroglutamate derivative [ J ]. Tetrahedron, 2009,65(1) :128-133.
  • 8李振江,万红贵,韦萍,石玉瑚,欧阳平凯.手性辅基法不对称合成特殊结构α-氨基酸——甘氨酸等当体途径[J].有机化学,2005,25(8):881-892. 被引量:10
  • 9BELOKON Y N. (S)-2-[ N-(N'-Benzylprolyl) amino] benzopheone ( BPB ) -a reagent for the synthesis of optically pure a-amino acids [ J ]. Jassen Chim. Acta, 1992, 10 (2) :4-12.
  • 10BELOKON Y N,KOCHETKOV K A,CHURKINA T D, et al. The first example of asymmetric Michael reaction catalyzed by ehiral alkali metal alkoxides [ J ]. Rus. Chem. Bull. , 1998,47 ( 1 ) : 74-81.

二级参考文献158

  • 1Baltz R H,Miao V, Wrigley S ICNatural products to drug:daptomycin and related lipopeptide antibiotics [J].Nat Prod Rep, 2005;22(6):717-741
  • 2Hill J,Siedlecld J, Parr I, et al.Synthesis and biological activity of N- Acylated ornithine analogues ofdaptomycin[J].Bioorg Med Chem Lett,2003;13(23):4187-4191
  • 3Boaretti M, Canepari P.-Purificad-on ofdaptomycin binding proteins (DBPs) from the membrane of Enter ococcus kirae[J].New Microbiol, 2000;23:305-317
  • 4Schriever C A, Femandez C, Rodvold K A,et a.LDaptomycin:A novel cyclic lipopeptide antimicrobial[J].Am J Health syst Pharm, 2005;62(11):1145-1158
  • 5Silverman J A, Perlmutter N G, Shapiro H M.Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus atzreus [J].Anfimicrob Agents Chemother, 2003;47(8):2538-2544
  • 6Barry AL, Fuchs PC,Brown SD.In vitro activities of daptomycin against 2789 clinical isolates from 11 North American medical centers [J]. Antimicrob Agents Chemother,2001; 45(6):1919-1922
  • 7Streit JM,Jones RN, Sader HS.Daptomycin activity and spectrumaworldwide sample of 6737 clinical gram-positive organisms[J]J antimicrob Chemother.2004;53 (4):669-674
  • 8Safdar N, Andes D, Craig WA.In vivo pharmacodynamic activity of daptomycin[J].Antimicrob Agents Chemother, 2004;48(1):63-68
  • 9Alder JD.Daptomycin,a new drug class for the treatment of Gam -postive in functions [J].Drugs Today,2005;41(2):81-90
  • 10Mohan SS, McDermott BP, Cunha BA.Methicinin-resistant Staphylococcus aureus prosthetic aortic valve endocardids with paravalvular abscess treated with daptomycin[J].Heart Lung, 2005;34:69-71

共引文献32

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部